Cell death following the loss of ADAR1 mediated A-to-I RNA editing is not effected by the intrinsic apoptosis pathway

被引:0
|
作者
Carl R. Walkley
Benjamin T. Kile
机构
[1] St. Vincent’s Institute of Medical Research,Department of Medicine, St. Vincent’s Hospital, Melbourne Medical School
[2] University of Melbourne,Mary MacKillop Institute for Health Research
[3] Australian Catholic University,Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute
[4] Monash University,undefined
[5] University of Adelaide,undefined
来源
Cell Death & Disease | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Modifications of RNA, collectively termed as the epitranscriptome, are widespread, evolutionarily conserved and contribute to gene regulation and protein diversity in healthy and disease states. There are >160 RNA modifications described, greatly exceeding the number of modifications to DNA. Of these, adenosine-to-inosine (A-to-I) RNA editing is one of the most common. There are tens of thousands of A-to-I editing sites in mouse, and millions in humans. Upon translation or sequencing an inosine base is decoded as guanosine, leading to A-to-G mismatches between the RNA and DNA. Inosine has different base pairing properties to adenosine and as a result editing not only alters the RNA code but can also change the RNA structure. In mammals A-to-I editing is performed by ADAR1 and ADAR2. A feature of murine loss of function ADAR1 alleles is cell death and a failure to survive embryogenesis. Adar1−/− and editing deficient (Adar1E861A/E861A) mice die between E11.75–13.5 of failed hematopoiesis. Strikingly this phenotype is rescued by the deletion of the cytosolic dsRNA sensor MDA5 or its downstream adaptor MAVS, a mechanism conserved in human and mouse. Current literature indicates that the loss of ADAR1 leads to cell death via apoptosis, yet this has not been genetically established. We report that blockade of the intrinsic (mitochondrial) apoptosis pathway, through the loss of both BAK and BAX, does not rescue or modify the cellular phenotype of the fetal liver or extend the lifespan of ADAR1 editing deficient embryos. We had anticipated that the loss of BAK and BAX would rescue, or at least significantly extend, the gestational viability of Adar1E861A/E861A embryos. However, the triple mutant Adar1E861A/E861ABak−/−Bax−/− embryos that were recovered at E13.5 were indistinguishable from the Adar1E861A/E861A embryos with BAK and BAX. The results indicate that cell death processes not requiring the intrinsic apoptosis pathway are triggered by MDA5 following the loss of ADAR1.
引用
收藏
相关论文
共 50 条
  • [41] ZBP1 induces immunopathology caused by loss of ADAR1-mediated RNA editing
    Minton, Kirsty
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (09) : 531 - 531
  • [42] ZBP1 induces immunopathology caused by loss of ADAR1-mediated RNA editing
    Kirsty Minton
    Nature Reviews Immunology, 2022, 22 : 531 - 531
  • [43] GGNBP2 regulates MDA5 sensing triggered by self double-stranded RNA following loss of ADAR1 editing
    Heraud-Farlow, Jacki E.
    Taylor, Scott R.
    Chalk, Alistair M.
    Escudero, Adriana
    Hu, Shi-Bin
    Goradia, Ankita
    Sun, Tao
    Li, Qin
    Nikolic, Iva
    Li, Jin Billy
    Fidalgo, Miguel
    Guallar, Diana
    Simpson, Kaylene J.
    Walkley, Carl R.
    SCIENCE IMMUNOLOGY, 2024, 9 (101)
  • [44] N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses
    Terajima, Hideki
    Lu, Mijia
    Zhang, Linda
    Cui, Qi
    Shi, Yanhong
    Li, Jianrong
    He, Chuan
    PLOS BIOLOGY, 2021, 19 (07)
  • [45] CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies
    Chen, Jian
    Li, Lu
    Liu, Tian-Yu
    Fu, Hua-Feng
    Lai, Yuan-Hui
    Lei, Xiong
    Xu, Jun-Fa
    Yu, Ji-Shang
    Xia, Yu-Jian
    Zhang, Tian-Hao
    Yang, Dong-Jie
    He, Yu-Long
    ONCOGENE, 2022, 41 (41) : 4591 - 4605
  • [46] CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies
    Jian Chen
    Lu Li
    Tian-Yu Liu
    Hua-Feng Fu
    Yuan-Hui Lai
    Xiong Lei
    Jun-Fa Xu
    Ji-Shang Yu
    Yu-Jian Xia
    Tian-Hao Zhang
    Dong-Jie Yang
    Yu-Long He
    Oncogene, 2022, 41 : 4591 - 4605
  • [47] CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients
    Dong, Xiuqing
    Chen, Geng
    Cai, Zhixiong
    Li, Zhenli
    Qiu, Liman
    Xu, Haipo
    Yuan, Yuan
    Liu, Xiaolong
    Liu, Jingfeng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) : 2602 - 2612
  • [48] RNA editing enzyme ADAR1 is required for early T cell development (Vol 2, Pg 27, 2020)
    Xufeng, Richard
    Nie, Daibang
    Yang, Qiong
    Wang, Wang
    Cheng, Tao
    Wang, Qingde
    BLOOD SCIENCE, 2021, 3 (03):
  • [49] RNA editing enzyme ADAR1 drives leukemia stem cell differentiation and self-renewal in chronic myeloid leukemia
    Jiang, Qingfei
    Leu, Heather
    Shih, Alice
    Goff, Daniel
    Court-Recart, Angela
    Ma, Wenxue
    Smith, Kristen
    Sadarangani, Anil
    Geron, Ifat
    Barrett, Christian
    Frazer, Kelly A.
    Crews, Leslie A.
    Jamieson, Catriona H. M.
    CANCER RESEARCH, 2012, 72
  • [50] ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit
    Riella, Cristian, V
    McNulty, Michelle
    Ribas, Guilherme T.
    Tattersfield, Calum F.
    Perez-Gill, Chandra
    Eichinger, Felix
    Kelly, Jessica
    Chun, Justin
    Subramanian, Balajikarthick
    Guizelini, Dieval
    Alper, Seth L.
    Pollak, Martin R.
    Sampson, Matthew G.
    Friedman, David J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (44)